AKT1 and Insulin resistance: Additionally, 1-Deoxynojirimycin supplementation appeared to improve muscle insulin resistance by modulating the IRS-1/PI3K/AKT pathway in the skeletal muscle of db/db mice (Kang et al., 2022).